Dual Plane vs Submuscular vs Subglandular Breast Augmentation: Complete Explanation Guide

Breast augmentation implant placement comes in three distinct anatomical planes — submuscular (under the pectoralis muscle), subglandular (above the muscle, under the gland), and dual plane (partial muscle release that combines both). The choice is not surgeon preference but a structured match between your soft-tissue thickness, breast base width, nipple-to-fold distance, and implant profile. This complete guide explains how Korean plastic surgeons triage placement decisions and where each plane outperforms the others for long-term outcome, palpability, animation deformity risk, and revision profile.

1. The three planes — anatomy and naming

Subglandular placement positions the implant above the pectoralis major muscle and below the breast gland. The implant lies directly behind the breast tissue.

Submuscular placement positions the implant fully under the pectoralis major muscle, with the lower portion of the implant also covered by the muscle's inferior origin. This was the dominant placement in 1990s-2000s Korean and Western practice.

Dual plane placement, developed by John Tebbetts and widely adopted in Korean practice since the 2010s, releases the inferior origin of the pectoralis from the rib so that the upper implant pole sits behind muscle while the lower pole sits in the subglandular plane. Three sub-variants (Dual Plane I, II, III) differ in how much glandular release accompanies the muscle release. Korean surgeons most commonly perform Dual Plane I or II for primary augmentation in Asian breast anatomy.

2. When subglandular is the right choice

Subglandular placement is indicated when the patient has adequate soft-tissue coverage (pinch test above the upper pole >2 cm), moderate-to-large native breast volume seeking modest augmentation, and minimal ptosis. The advantage: shorter recovery, no animation deformity (the implant does not move when the pectoralis contracts), and easier surgical access for combined mastopexy.

The disadvantages relevant to long-term outcome: higher palpability and visibility risk in thin patients, higher capsular contracture rate in some published series (older data, with debated current relevance), and complicated mammography interpretation. In Korean practice, subglandular is less commonly chosen than dual plane because the predominant patient profile (slim, low BMI, thin upper pole) does not match the indication well.

3. When submuscular is the right choice

Full submuscular placement is indicated for very thin patients (pinch test <1.5 cm), revision cases with prior capsular contracture, and patients seeking maximum implant concealment. The advantage: best implant coverage in thin tissue, reduced palpability, easier mammography.

The disadvantages: animation deformity (implant distortion during pectoralis contraction — visible during exercise, lifting, and even some daily movement), longer recovery due to muscle disruption, and a tendency for the implant to ride high if the inferior muscle origin is not properly released. For Asian breast anatomy, full submuscular often produces an unnatural high-set, square-shaped upper pole that international patients commonly want to avoid.

4. When dual plane is the right choice

Dual plane is the most commonly used Korean primary augmentation placement for women with low-to-moderate native breast volume, thin-to-moderate soft tissue, and a desire for both natural upper-pole slope and adequate lower-pole projection. The technique combines the upper-pole coverage benefit of submuscular with the lower-pole shape benefit of subglandular.

Dual Plane I (minimal gland release) suits women with a glandular-skin relationship that supports natural draping. Dual Plane II (release to lower areolar border) and Dual Plane III (release to upper areolar border) progressively address greater ptosis or glandular tightness. The selection between I/II/III is anatomy-specific and is part of the surgeon's diagnostic decision, not patient preference.

5. Implant profile, projection, and base-width matching

Placement plane is one of three interdependent variables; the others are implant profile (low/moderate/high/extra-high projection) and implant base width (must match patient base width within 0.5-1 cm). A mismatched base width — implant wider than tissue support — risks lateral migration; narrower implant produces inadequate fill.

Korean surgeons commonly use round smooth Mentor or Motiva implants in 200-350cc range for primary augmentation in Asian anatomy. Anatomical (teardrop) implants exist but the rotation risk and lower-pole shape considerations make them less commonly chosen in current Korean practice. The Mentor MemoryGel Xtra and Motiva Ergonomix variants are the workhorses in 2024-2025 Korean primary cases.

6. Cost framework and Korean market pricing

Korean primary breast augmentation with premium implants (Mentor, Motiva) in Gangnam tier-1 clinics typically prices 8,000,000-13,000,000 KRW including implant cost, hospitalization (often 1 overnight), anesthesia, garment, and a 12-month follow-up. The price differential between subglandular, submuscular, and dual plane is minimal at most clinics — the choice is anatomical, not financial.

International patients should verify what is and is not included: revision policy (some clinics include 1-year revision for capsular contracture or implant rupture in price; others bill separately), the specific implant brand and model with documentation, the warranty registration status (Mentor and Motiva implants come with manufacturer lifetime warranty when registered), and post-discharge garment, pain management, and complication protocol. A 2024 KHIDI consumer advisory noted implant brand substitution as a recurring international patient complaint.

7. Recovery timeline and animation deformity reality

Dual plane and submuscular recovery extends 4-6 weeks for return to upper-body exercise, 6-8 weeks for full normal activity. Subglandular recovery is shorter — 2-3 weeks for most activities. Korean clinics commonly use surgical bra and chest band protocols for 4-6 weeks post-op regardless of plane.

Animation deformity (implant distortion during pectoralis contraction) affects submuscular and dual plane patients to varying degrees. Dual plane reduces but does not eliminate animation. Subglandular has no animation deformity. Patients with high pectoralis activity (athletes, fitness enthusiasts) should discuss this trade-off explicitly with their surgeon, as animation can be visible during exercise even years post-op.

8. Long-term outcome and revision considerations

Capsular contracture is the most common long-term complication, with reported rates varying widely by study (2-15% over 10 years). Subglandular placement has historically been associated with higher rates, though contemporary studies dispute the magnitude when using textured or microtextured implants and modern sterile technique. Dual plane currently shows the best balance of contracture rates and natural outcome in published Korean series.

Revision triggers include capsular contracture (Baker grade III/IV), implant rupture (silicone or saline), malposition, size change desire, and bottoming out. Average primary implant lifespan is 10-15 years before some patients seek revision, though many implants last 20+ years without indication for revision. International patients should plan a 12-month and 5-year follow-up with their Korean surgeon, or arrange equivalent monitoring with a qualified surgeon at home.

FAQ

The most common international-patient questions on breast implant placement.

Can I switch placements in a revision surgery?

Yes, plane conversion is performed in revision cases — subglandular to submuscular conversion for capsular contracture or implant edge visibility; submuscular to subglandular conversion if animation deformity is unacceptable. Conversion adds complexity and downtime versus simple implant exchange, and outcomes depend on tissue quality remaining after prior surgery.

Is dual plane always better than subglandular?

No. Dual plane is the best fit for the most common Korean primary patient anatomy (thin soft tissue, low native volume) but a patient with abundant native breast tissue and minimal ptosis may achieve better and more natural outcomes with subglandular. The diagnostic step matters more than the plane name.

How long is hospitalization for Korean breast augmentation?

Most Korean clinics keep primary augmentation patients overnight (1 night) for pain management and drain monitoring, with discharge the morning after surgery. Some clinics offer same-day discharge with private nurse arrangement. International patients should stay in Korea for at least 7-10 days for the first follow-up and suture removal.

What is the safest implant in 2026?

No implant is risk-free. Smooth-shell round silicone implants (Mentor MemoryGel Xtra, Motiva Ergonomix SmoothSilk) currently have the most favorable safety profile in published surveillance data. Textured implants are still used but reserved for specific indications due to historical BIA-ALCL association. KFDA-approved implants in Korean practice are tracked through national registries — confirm your implant is registered.

Can I breastfeed after breast augmentation?

The majority of patients retain breastfeeding ability after augmentation regardless of plane, when the incision approach preserves the milk ducts. Inframammary fold incision (most common in Korean practice) preserves duct anatomy. Periareolar incision has slightly higher risk of duct disruption. Discuss future breastfeeding plans with your surgeon if relevant.

Related Reading

How to Vet a Korean Clinic | Botox vs Filler Decision Framework | V-line Surgery: Bone vs Fat vs Buccal Fat

Sources & References

The clinical claims in this article reference the following sources from official Korean medical authorities and peer-reviewed publications.

KHIDI Medical Korea | KSPRS | PubMed

Last Medically Reviewed

Last medically reviewed: 2026-05-25 by the Korean Plastic Surgery medical editorial team. Reviewed for adherence to KSPRS guidelines, KHIDI international patient standards, and current Korean clinical practice. Article will be updated within 12 months.